Celestica (CLS) Stock Falls Amid Market Uptick: What Investors Need to Know

Celestica (CLS) shares experienced a 2.85% decline to $163.98, underperforming the S&P 500's modest gain, despite the stock's recent 13.25% outperformance against broader markets and its sector. This movement precedes the company's Q2 2025 earnings release on July 28, 2025, where it is projected to report significant year-over-year growth, with EPS forecasted at $1.24 (+36.26%) and revenue at $2.67 billion (+11.66%). Analysts maintain a positive outlook, reflected in a Zacks Rank #2 (Buy) and recent upward estimate revisions, though the stock trades at a forward P/E of 33.29, a notable premium to its industry average of 21.84.

Analysis

Celestica (CLS) exhibited a short-term divergence from its recent momentum, declining 2.85% to $163.98 against a backdrop of modest gains in the broader S&P 500 and Nasdaq indices. This single-day pullback contrasts sharply with its significant outperformance in the preceding period, where the stock surged 13.25%, outpacing both its sector and the S&P 500. The market's focus is now firmly on the company's upcoming earnings report on July 28, 2025, which carries high expectations. Consensus estimates project substantial year-over-year growth, with quarterly EPS forecasted at $1.24 (+36.26%) on revenue of $2.67 billion (+11.66%). This bullish outlook is reinforced by full-year projections expecting over 30% EPS growth and is further supported by a Zacks Rank #2 (Buy) and an upward revision in the consensus EPS estimate over the past month. However, this optimism is reflected in the stock's valuation, which at a Forward P/E of 33.29, trades at a notable premium to its industry average of 21.84, suggesting that strong execution is already priced in.

Key Decisions for Investors

• Investors should consider the recent 2.85% price decline as a potential entry point, contingent on their conviction in the company's ability to meet the high growth expectations of over 36% YoY EPS growth.
• The premium Forward P/E of 33.29 versus the industry's 21.84 implies significant risk if the upcoming earnings report on July 28, 2025, fails to meet or beat consensus estimates.
• Monitor Celestica's performance relative to its industry, which is highly ranked in the top 5% by Zacks, as continued industry strength could provide a tailwind for the stock despite its high valuation.